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Spontaneous regression (SR) refers to the “partial or com-plete disappearance of a malignant tumor in the absence of 
all treatment or in the presence of therapy which is considered 
inadequate to exert a significant influence on neoplastic dis-
ease”.1 SR is a rare event, estimated to occur in one in 60,000 
to one in 100,00 cases of cancer.2 Although there are reports 
of SR occurring in different malignancies, many cases of SR 
occur among patients with renal cell carcinoma, non-Hodg-
kin’s lymphoma, malignant melanoma, chronic lymphoid leu-
kemia, and neuroblastoma.3
We describe the first case in the literature of SR of meta-
static non–small-cell lung cancer (NSCLC) in the setting of 
immune reconstitution in an HIV positive individual.
At diagnosis, the patient was a 44-year-old male smoker 
with a past medical history significant for HIV/AIDS diag-
nosed 20 years earlier, neurosyphilis, and toxoplasmosis, who 
presented with a severe headache, photophobia, nausea, and 
vomiting. At the time of his initial presentation, his CD4 count 
was 77 cells/mm3 and he had not been adherent to his highly 
active antiretroviral therapy regimen (HAART). Brain imag-
ing revealed a 1.7 × 1.8 cm ring-enhancing lesion in the pos-
terior right parietal lobe with significant edema and midline 
shift. He was empirically treated for toxoplasmosis without 
clinical or radiologic improvement.
Craniotomy and excision of the brain mass revealed a 
poorly differentiated non–small-cell carcinoma with immuno-
histochemical staining positive for low molecular weight cyto-
keratin and negative for CK7, CK20, and HMB45 consistent 
with poorly differentiated NSCLC. CT revealed a right upper 
lobe nodule (17 × 9 mm), a right adrenal mass (47 × 41 mm), 
and a heterogeneous mass anterior to the pancreatic body 
(23 × 24 mm). Biopsies of both the adrenal gland and lung 
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FIGURE 1.  The columns of this 
diagram show CT images at diagno-
sis, 4 months post-diagnosis, and 21 
months post-diagnosis. The first row 
shows the primary lung lesion, the 
second row the adrenal lesion, and 
the third row the pancreatic lesion. 
The axial slices in which the lesion 
was largest are shown. By the last 
column, both the adrenal lesion and 
the pancreatic lesion have resolved.
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revealed TTF-1 positive, poorly differentiated carcinoma with 
extensive necrosis consistent with a primary lung malignancy.
The patient received whole brain radiotherapy, 3000 
cGy in 10 fractions and therapy with HAART was re-initiated. 
Soon after, his CD4 count had increased to 104 cells/mm3 
and repeat brain imaging did not reveal any areas of residual 
enhancement to suggest persistent tumor activity.
Because of the patient’s poor performance status, no 
further antineoplastic therapy was given and radiographic 
surveillance was initiated with serial follow-up CT scans 
every 4–6 months. The patient remains compliant with 
HAART and his CD4 counts have been consistently greater 
than 200 cells/mm3.
Serial imaging has demonstrated progressive diminu-
tion of the pulmonary, adrenal, and pancreatic lesions without 
the appearance of new lesions (Fig. 1). At 5-year follow-up, 
the lung lesion measured 11 × 5 mm and no adrenal or pancre-
atic masses were seen.
Although patients with HIV typically are thought to 
have a more aggressive course, this may not be the case in 
the HAART era.4 Novel immune therapies such as anti-PD-1/
PD-L1 antibodies have recently demonstrated remarkable 
responses in a subset of patients with NSCLC.5 This case 
provides the first reported case of a SR of metastatic non–
small-cell lung cancer consequent to immune reconstitution 
and underscores the potential role of the immune system in 
combating NSCLC.
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